Dr. Stanley Jordan, MD

Dr. Jordan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Jordan's NPI, 1669432167, was assigned on March 27, 2006. Dr. Jordan graduated from University of North Carolina School of Medicine in 1973. Dr. Jordan holds California license A26161.

Dr. Jordan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Jordan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Jordan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jordan practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Jordan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Jordan is board certified in diagnostic laboratory immunology by the American Board of Pediatrics. Dmand AI has Dr. Jordan's licenses on file in 2 states: California and North Carolina.

Dmand AI lists acute kidney failure, chronic diabetes, chronic hypertension, kidney disease, overactive thyroid, parathyroid gland disorder and underactive thyroid among the conditions Dr. Jordan treats.

CMS data shows 275 Medicare services from Dr. Jordan across 5 procedure codes in 2024, for 176 Medicare patients. Medicare paid $19,315 for them.

CMS counts 176 Medicare patients who saw Dr. Jordan in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 36% are also on Medicaid. Their average risk score is 4.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jordan's median patient age at 62, with 41% women.

In 2024, Dr. Jordan wrote 625 Medicare Part D claims for 118 patients. 84% of them were for generic drugs. CMS names the drug for 453 of them, across 13 drugs with 11 or more claims each, at $395,587 in total drug cost. In 2023, CMS named 560 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Jordan for performance year 2024, reported as part of a group. Dr. Jordan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jordan as offering telehealth.

Dmand AI links 235 papers to Dr. Jordan, published from 2003 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Graft Rejection, Kidney Transplantation and HLA Antigens. Dr. Jordan has published most often in Transplantation. Dr. Jordan's most frequent co-authors are Edmund Huang, MD, Alberto M. Marchevsky, MD and Asha Moudgil, MD.

Dmand AI links Dr. Jordan to 16 clinical trials, 10 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Kidney Failure, Chronic, Renal Insufficiency, Chronic and Rejection, Psychology. Cedars-Sinai Medical Center sponsors the most, 8.

CMS Open Payments shows 177 general payments to Dr. Jordan from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. CSL Behring paid the most, $69,125. It also lists 2 research payments totaling $739 in 2022.

Dmand AI lists 5 awards for Dr. Jordan, most recently America's Top Doctors in 2014.

Dr. Jordan graduated from University of North Carolina School of Medicine in 1973.

Dr. Jordan is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.